US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AdvisorShares Psychedelics ETF

24.53

+0.03400.14%

Volume:14.63K

Turnover:357.03K

Market Cap:56.92M

PE:- -

High:24.57

Open:24.35

Low:24.35

Close:24.50

52wk High:27.02

52wk Low:15.63

Shares:2.32M

Float Shares:2.32M

Volume Ratio:0.73

T/O Rate:0.63%

Dividend:1.71

Dividend Rate:6.95%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Alkermes Appoints Anne Whitaker to Board of Directors

Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors

THOMSON REUTERS

Compass Pathways Joins TD Cowen Novel Mechanisms in Neuropsychiatry Summit Fireside Chat

NRx Pharma Says FDA Reclassifies Ketamine ANDA Amendment as Minor, Sets Nov. 10, 2026 Goal Date

NRx Pharmaceuticals says FDA reclassifies ANDA amendment to ‘minor’

NRX Pharmaceuticals - FDA Revises Gdufa Goal Date for Anda Amendment to November 10, 2026

THOMSON REUTERS

NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine

As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards

Compass Pathways Launches ‘Change the Tune in Trd’ in the U.S. to Advance Hcp Understanding of Treatment-Resistant Depression at Psych Congress 2026

THOMSON REUTERS

Dataworks Group Plans Share and Option Issue to Support Growth

Dataworks launches A$4.24m capital raising to fund growth and strengthen balance sheet

Flynn Gold halts ASX trading ahead of capital raising announcement

Experts Urge FDA to Set Clear Safety and Access Standards for Psychedelic Drugs

NRX Pharmaceuticals Price Target Maintained with a $10.00/Share by BTIG

FDA to Hold Public Hearing on Psychedelic Drugs as Trump-Driven Push Gathers Pace

NRx Pharma Unit GeNeuro Wins European Patent for ALS Antibody Candidate GNK-301

InFocus Group Raises $465,000 to Back New Products and Gaming Tech

Strata Mental Health Solutions awarded training grant by Compass Pathways

Relmada Therapeutics Shares Rise After CEO, CFO Buy 200,000 Shares Each

MT Newswires Live

Dupixent’s Next Move: STYLE 1 Itch Study Wraps Up for Regeneron and Sanofi

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/PSIL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PSIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","market":"US","secType":"STK","nameCN":"AdvisorShares Psychedelics ETF","latestPrice":24.534,"timestamp":1789574568376,"preClose":24.5,"halted":0,"volume":14633,"delay":0,"changeRate":0.0013877551020407722,"floatShares":2319976,"shares":2319976,"eps":0,"marketStatus":"Trading","change":0.034,"latestTime":"09-16 12:13:07 EDT","open":24.35,"high":24.5699,"low":24.35,"amount":357029.001269,"amplitude":0.008976,"askPrice":24.87,"askSize":100,"bidPrice":24.31,"bidSize":1000,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":24.5,"sharesOutstanding":1184976,"nav":25.051,"aum":58118072.21,"dividendRate":0.069504,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":25.06,"preClose":24.5,"latestTime":"08:44 EDT","volume":39,"amount":972.7199820000001,"timestamp":1789562657590,"change":0.56,"changeRate":0.022857,"amplitude":0.039592},"postHourTrading":{"tag":"盘后","latestPrice":25.52,"preClose":24.5,"latestTime":"19:30 EDT","volume":168,"amount":4296.44,"timestamp":1789515005327,"change":1.02,"changeRate":0.041633,"amplitude":0.041633},"volumeRatio":0.725971,"impliedVol":0.5467,"impliedVolPercentile":0.9044},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","floatShares":2319976,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.725971,"shares":2319976,"dividePrice":1.7052,"high":24.5699,"amplitude":0.008976,"preClose":24.5,"low":24.35,"week52Low":15.6348,"pbRate":"--","week52High":27.0175,"institutionHeld":0,"latestPrice":24.534,"committee":0.818182,"eps":0,"divideRate":0.069504,"volume":14633,"delay":0,"ttmEps":0,"open":24.35,"prevYearClose":17.17,"prevWeekClose":24.7682,"prevMonthClose":24.62,"prevQuarterClose":24.05,"fiveDayClose":25.21,"twentyDayClose":26.2,"sixtyDayClose":21.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSIL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PSIL","amount":1.68387,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2025-09-22","symbol":"PSIL","amount":0.02007,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-29"},{"date":"2025-06-23","symbol":"PSIL","amount":0.01191,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-21","symbol":"PSIL","amount":0.16343,"announcedDate":"2025-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSIL","amount":0.05477,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSIL\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-26","recordDate":"2022-09-27","paymentDate":"2022-09-30","value":0.05421,"currency":"USD"},{"executeDate":"2023-09-25","recordDate":"2023-09-26","paymentDate":"2023-09-29","value":0.00336,"currency":"USD"},{"executeDate":"2024-09-23","recordDate":"2024-09-23","paymentDate":"2024-09-30","value":0.1087,"currency":"USD"},{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.05477,"currency":"USD"},{"executeDate":"2025-03-21","recordDate":"2025-03-21","paymentDate":"2025-03-28","value":0.16343,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSIL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSIL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667607455","title":"Alkermes Appoints Anne Whitaker to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607455","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667607455?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:00","pubTimestamp":1789556448,"startTime":"0","endTime":"0","summary":"Alkermes appoints Anne Whitaker to board of directorsAlkermes appointed Anne C. Whitaker as an independent director to its board.Whitaker is a biopharmaceutical executive with commercial, operational,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL86gXCW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","PSCH","IBRN","ALKS","MEDX","BK4139","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607123","title":"Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607123","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667607123?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:00","pubTimestamp":1789556400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA78XSXG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","PSIL","ALKS","MEDX","FBT","BK4139","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667460228","title":"Compass Pathways Joins TD Cowen Novel Mechanisms in Neuropsychiatry Summit Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2667460228","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667460228?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:30","pubTimestamp":1789554631,"startTime":"0","endTime":"0","summary":"Compass Pathways joins TD Cowen Novel Mechanisms in Neuropsychiatry Summit fireside chatCompass Pathways will attend TD Cowen’s 6th Annual Novel Mechanisms in Neuropsychiatry Summit on Sept. 23, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL1sXVMd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","PSIL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667604726","title":"NRx Pharma Says FDA Reclassifies Ketamine ANDA Amendment as Minor, Sets Nov. 10, 2026 Goal Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2667604726","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667604726?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:04","pubTimestamp":1789553080,"startTime":"0","endTime":"0","summary":"NRx Pharma says FDA reclassifies ketamine ANDA amendment as minor, sets Nov. 10, 2026 goal dateNRX Pharmaceuticals received FDA notice reclassifying its ketamine ANDA amendment from major to minor, ea","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL16nC4D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PSIL","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667621742","title":"NRx Pharmaceuticals says FDA reclassifies ANDA amendment to ‘minor’","url":"https://stock-news.laohu8.com/highlight/detail?id=2667621742","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667621742?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:15","pubTimestamp":1789499711,"startTime":"0","endTime":"0","summary":"NRx Pharmaceuticals (NRXP) announced that it has received a written communication from the Director of Regulatory Operations of the FDA Office of G...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nrx-pharmaceuticals-says-fda-reclassifies-anda-amendment-to-minor-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nrx-pharmaceuticals-says-fda-reclassifies-anda-amendment-to-minor-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NRXP","PSIL","BK4585","BK4588","LABU","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667621265","title":"NRX Pharmaceuticals - FDA Revises Gdufa Goal Date for Anda Amendment to November 10, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667621265","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667621265?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:11","pubTimestamp":1789499515,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570DV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667624858","title":"NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine","url":"https://stock-news.laohu8.com/highlight/detail?id=2667624858","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667624858?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:11","pubTimestamp":1789499460,"startTime":"0","endTime":"0","summary":"Abbreviated New Drug Application (ANDA) Amendment related to the drug vial for preservative-free ketamine has been reclassified from a Major Amendment to a Minor Amendment.FDA has revised the Generic ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/15/3362609/0/en/nrx-pharmaceuticals-nasdaq-nrxp-reports-update-from-the-fda-revising-previous-major-amendment-to-a-minor-amendment-for-preservative-free-ketamine.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","NRXP","LCLG","BK4585","BK4007","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667862533","title":"As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards","url":"https://stock-news.laohu8.com/highlight/detail?id=2667862533","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667862533?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:16","pubTimestamp":1789485372,"startTime":"0","endTime":"0","summary":"The strongest evidence for use of the drugs so far has come from trials in patients with severe depression or post-traumatic stress disorder who have not responded to existing treatments.Early-stage trials are also testing psychedelic drugs for substance abuse disorders, borderline personality disorder, obsessive-compulsive disorders, anxiety, self-harm behavior, chronic Lyme disease and fibromyalgia.HOW DO PSYCHEDELIC TREATMENTS WORK?Psychedelic treatments work primarily by activating proteins on the surface of nerve cells that regulate the brain's ability to reorganize, form new connections, and repair damaged circuits. Unlike traditional psychiatric drugs that may be taken at home on a daily basis, these treatments are usually administered by medical personnel in a limited number of sessions to supplement intensive psychotherapy.WHAT PSYCHEDELIC DRUGS ARE CURRENTLY AUTHORIZED FOR USE?In the U.S. and Europe, the leading candidate for authorization is psilocybin, the active ingredient","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL1N4570B8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4533","LU0098860793.USD","BK4568","IE00B19Z3581.USD","LU0345770993.USD","LU2430703095.HKD","LU2133065610.SGD","LU1196500208.SGD","IE000SO60NU8.SGD","IE00BKVL7J92.USD","SGXZ57979304.SGD","LU0545562505.USD","LU2129689605.HKD","IE0009355771.USD","LU1778281490.HKD","LU0289739699.SGD","LU1244550577.SGD","IE000BZT7R73.USD","LU1057294990.SGD","IHE","LU1066053197.SGD","LU2468319806.SGD","LU1496350502.SGD","LU2112291526.USD","IE00B3T34201.USD","BK4139","BK4581","FTXH","LU0795875086.SGD","LU0069063385.USD","LU1244550221.USD","LU1983299246.USD","LU0114720955.EUR","LU1629891620.HKD","LU0058720904.USD","LU1074936037.SGD","LU1506573853.SGD","LU2750360641.GBP","IE000F7OJYX1.SGD","LU0640476718.USD","BK4504","IE000WAW04H5.SGD","LU2456880835.USD","LU0289739343.SGD","LU2592432038.USD","LU0432979614.USD","LU0683600562.USD","IYH","LU0795875169.SGD","LU0964807845.USD","SG9999001176.SGD","TRUH","SG9999001440.SGD","LU1043141396.HKD","IE00B4R5TH58.HKD","LU1551013342.USD","LU1043141123.HKD","IE00BGHQF631.EUR","BK4534","LU1228905540.USD","LU1929549753.HKD","IE00BLSP4239.USD","IE00B3PB1722.GBP","LU0162691827.USD","LU2471134523.USD","LU2896262040.SGD","LU0689626769.HKD","SG9999013999.USD","LU0787776722.HKD","LU0122379950.USD","LU1718418525.SGD","PBM","LU2430703178.SGD","LU2602419157.SGD","LU2471134796.USD","BK4588","IE00BVYPNW00.USD","SG9999001176.USD","LU0820562030.AUD","LU0072461881.USD","LU1261432733.SGD","LU1732799900.SGD","IE00BSNM7G36.USD","BK4559","LU0057025933.USD","LU1989771016.USD","LU1066051225.USD","BK4007","IE00BVYPNV92.GBP","LU0203347892.USD","PJP","IE00BN8TJ469.HKD","LU2756315664.SGD","LU1121112475.USD","LU1267930813.SGD","IE00BFTCPJ56.SGD","LU0320765646.SGD","IE00B2B36J28.USD","LU1894683348.USD","IE00BLSP4452.SGD","LU1244550494.USD","BK4550","LU0203345920.USD","IE00B7SZLL34.SGD","GDOC","LU1894683264.USD","LU0689472784.USD","LU0889566641.SGD","LU2430703251.USD","PSIL","LU1061106388.HKD","LU2505996509.AUD","LU1674673691.USD","LU0943347566.SGD","BK4592","LU1674673428.USD","LU0912757837.SGD","LU0289961442.SGD","IE0000B7K699.USD","LU0792757196.USD","LU1066051811.HKD","LU0234572021.USD","IE0002270589.USD","IE000M9KFDE8.USD","IXJ","RXL","LU2089984988.USD","LU0820561909.HKD","LU0994945656.USD","LU2471134879.HKD","CMPS","LU1551013425.SGD","LU1032955483.USD","LU1585245621.USD","LU1162221912.USD","LU0210536198.USD","LU1430594728.SGD","LU2023250330.USD","LU2347655156.SGD","BMED","LU2213496289.HKD","LU0820561818.USD","LU1291159041.SGD","LU2471134952.CNY","VHT","SG9999002224.SGD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU1221951129.SGD","IE0001KFT4U8.USD","LU2756315318.SGD","LU0472753341.HKD","LU1032466523.USD","LU0426417589.USD","IE00B42XCP33.USD","LU1228905037.USD","IE0034235303.USD","LU0124676726.USD","LU2129689431.USD","LU0511384066.AUD","SG9999002232.USD","LU2750360997.AUD","BK4532","LU1732800096.USD","IE00BDGV0183.EUR","LU0345770308.USD","LU1221951046.USD","IE00BJJMRZ35.SGD","LU1935042991.SGD","FHLC","IE00BBT3K403.USD","LU1145028129.USD","MEDX","IE000MB6IJN5.SGD","IE0002141913.USD","LU0070217475.USD","LU2236285917.USD","LU0882574055.USD","LU1059921491.USD","JDOC","LU1280957306.USD","LU0345769128.USD","LU0210528500.USD","IE00BFXG1179.USD","LU2403377893.USD","LU0426412945.USD","LU1066051498.USD","LU1914381329.SGD","LU2417539215.USD","LU0345769631.USD","IE00BZ1G4Q59.USD","LU0985320562.USD","LU0466842654.USD","LU0053666078.USD","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","LU2129689514.USD","LU2487616109.SGD","SGXZ80539844.SGD","LU0234570918.USD","JNJ","LU2505996681.GBP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667462036","title":"Compass Pathways Launches ‘Change the Tune in Trd’ in the U.S. to Advance Hcp Understanding of Treatment-Resistant Depression at Psych Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667462036","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667462036?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:30","pubTimestamp":1789468200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUA90S5ST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667200691","title":"Dataworks Group Plans Share and Option Issue to Support Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2667200691","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667200691?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:54","pubTimestamp":1789430077,"startTime":"0","endTime":"0","summary":"IXUP Ltd. ( ($AU:DWG) ) has issued an announcement. Dataworks Group Limited has outlined plans for a new capital raising, proposing the issue of up...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dataworks-group-plans-share-and-option-issue-to-support-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dataworks-group-plans-share-and-option-issue-to-support-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691733","title":"Dataworks launches A$4.24m capital raising to fund growth and strengthen balance sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691733","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691733?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:54","pubTimestamp":1789430069,"startTime":"0","endTime":"0","summary":"IXUP Ltd. ( ($AU:DWG) ) has provided an announcement. Dataworks Group Limited has launched a capital raising of up to A$4.24 million comprising a A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dataworks-launches-a4-24m-capital-raising-to-fund-growth-and-strengthen-balance-sheet?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dataworks-launches-a4-24m-capital-raising-to-fund-growth-and-strengthen-balance-sheet?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","SPHQ","PSIL","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691316","title":"Flynn Gold halts ASX trading ahead of capital raising announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691316","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691316?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:18","pubTimestamp":1789427896,"startTime":"0","endTime":"0","summary":"Flynn Gold Ltd. ( ($AU:FG1) ) just unveiled an update. Flynn Gold has requested and received a trading halt on its securities on the ASX as it prep...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/flynn-gold-halts-asx-trading-ahead-of-capital-raising-announcement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/flynn-gold-halts-asx-trading-ahead-of-capital-raising-announcement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["159934","PSIL","MGCmain","SGCmain","SGUmain","GLD","GCmain","518880","DUST","IAU","GDX","NUGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693327","title":"Experts Urge FDA to Set Clear Safety and Access Standards for Psychedelic Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693327","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693327?lang=en_us&edition=fundamental","pubTime":"2026-09-15 03:30","pubTimestamp":1789414223,"startTime":"0","endTime":"0","summary":"UPDATE 2-Experts urge FDA to set clear safety and access standards for psychedelic drugsSept 14 (Reuters)-Doctors, veterans, pharmacists and therapists on Monday urged the U.S. Food and Drug Administr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL1N4560R3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATAI","BK4007","PSIL","GHRS","CMPS","DFTX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667698261","title":"NRX Pharmaceuticals Price Target Maintained with a $10.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2667698261","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667698261?lang=en_us&edition=fundamental","pubTime":"2026-09-15 02:51","pubTimestamp":1789411860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NRXP/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667454","title":"FDA to Hold Public Hearing on Psychedelic Drugs as Trump-Driven Push Gathers Pace","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667454","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667454?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:20","pubTimestamp":1789402802,"startTime":"0","endTime":"0","summary":"FDA to hold public hearing on psychedelic drugs as Trump-driven push gathers paceSept 14 (Reuters)-The U.S. Food and Drug Administration will hold a public hearing on Monday to gather feedback on the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4N4531CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","GHRS","PSIL","BK4139","BK4007","BK4539","CMPS","ATAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668873","title":"NRx Pharma Unit GeNeuro Wins European Patent for ALS Antibody Candidate GNK-301","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668873","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668873?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:04","pubTimestamp":1789383892,"startTime":"0","endTime":"0","summary":"NRx Pharma unit GeNeuro wins European patent for ALS antibody candidate GNK-301NRx Pharmaceuticals’ GeNeuro unit won a European patent covering GNK-301, a monoclonal antibody targeting HERV-K envelope","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL34d93C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","NDAQ","IE00B64PRP62.GBP","BK4588","LU2095319765.USD","BK4007","SG9999014005.SGD","BK4585","LU0314104364.USD","BK4021","IE00BQXX3D17.EUR","LU2210149790.SGD","BK4112","NRXP","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","SG9999014039.USD","IE00BQXX3C00.GBP","LU2210150020.SGD","IE00B3QW5Z07.USD","SG9999014021.USD","PSIL","GNK","IE00BGHQF748.EUR","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BKPKM429.USD","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667655067","title":"InFocus Group Raises $465,000 to Back New Products and Gaming Tech","url":"https://stock-news.laohu8.com/highlight/detail?id=2667655067","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667655067?lang=en_us&edition=fundamental","pubTime":"2026-09-14 15:37","pubTimestamp":1789371472,"startTime":"0","endTime":"0","summary":"The latest update is out from Frugl Group Limited ( ($AU:IFG) ). InFocus Group Holdings Limited has completed a capital raising of $465,000, includ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/infocus-group-raises-465000-to-back-new-products-and-gaming-tech?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/infocus-group-raises-465000-to-back-new-products-and-gaming-tech?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666257102","title":"Strata Mental Health Solutions awarded training grant by Compass Pathways","url":"https://stock-news.laohu8.com/highlight/detail?id=2666257102","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666257102?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:15","pubTimestamp":1789157710,"startTime":"0","endTime":"0","summary":"Strata Mental Health Solutions announced it has been awarded one of the five U.S. HCP training grants awarded by Compass Pathways (CMPS) to develop...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/strata-mental-health-solutions-awarded-training-grant-by-compass-pathways-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/strata-mental-health-solutions-awarded-training-grant-by-compass-pathways-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666311579","title":"Relmada Therapeutics Shares Rise After CEO, CFO Buy 200,000 Shares Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2666311579","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666311579?lang=en_us&edition=fundamental","pubTime":"2026-09-12 02:30","pubTimestamp":1789151447,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics  shares were up nearly 11% in afternoon trading on Friday after the company's Chief Executive Officer Sergio Traversa and Chief Financial Officer Maged Shenouda bought 200,000 shares each, according to separate regulatory filings.Trading volume stood at over 1.7 million shares against a daily average of about 1.8 million.Price: 4.52, Change: +0.44, Percent Change: +10.93","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4007","BK4539","LENZ","PSIL","RLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666057576","title":"Dupixent’s Next Move: STYLE 1 Itch Study Wraps Up for Regeneron and Sanofi","url":"https://stock-news.laohu8.com/highlight/detail?id=2666057576","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666057576?lang=en_us&edition=fundamental","pubTime":"2026-09-12 00:30","pubTimestamp":1789144227,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals ($REGN), Sanofi ($SNYNF) announced an update on their ongoing clinical study. The STYLE 1 study is a Phase 3 trial run by...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dupixents-next-move-style-1-itch-study-wraps-up-for-regeneron-and-sanofi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dupixents-next-move-style-1-itch-study-wraps-up-for-regeneron-and-sanofi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BK4007","SNYNF","BBC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}